Form 4: Thermo Fisher Scientific SVP Michael Boxer Executes Option and Sells Shares Under 10b5-1 Plan
SEC Form 4
Michael A. Boxer, SVP and General Counsel of Thermo Fisher Scientific, exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.
Summary
- On October 25, 2024, Michael A. Boxer, SVP and General Counsel of Thermo Fisher Scientific, exercised stock options to acquire 2,000 shares of common stock at a price of $210.68 per share.
- Simultaneously, Boxer sold 2,000 shares of Thermo Fisher Scientific common stock at a price of $560.16 per share.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on December 13, 2023.
- Following these transactions, Boxer directly owns 12,735.534 shares of Thermo Fisher Scientific common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-existing plan. There is no indication of positive or negative sentiment.
Positives
- The transactions were executed under a pre-existing 10b5-1 trading plan, which is generally viewed as a positive corporate governance practice.
Industry Context
Executive stock transactions are a normal part of corporate compensation. The use of a 10b5-1 plan indicates a pre-planned strategy to avoid insider trading concerns.
Comparison to Industry Standards
- Executive compensation practices, including stock options and trading plans, are common across publicly traded companies like Thermo Fisher Scientific.
- Companies such as Danaher, Agilent, and PerkinElmer also utilize similar compensation strategies for their executives.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders as they are part of a pre-planned trading strategy.
Key Dates
| Date | Description |
|---|---|
| December 13, 2023 | Date the reporting person adopted the Rule 10b5-1 trading plan. |
| February 27, 2019 | First vesting date of the stock option. |
| February 27, 2020 | Second vesting date of the stock option. |
| February 27, 2021 | Third vesting date of the stock option. |
| February 27, 2022 | Fourth vesting date of the stock option. |
| February 27, 2025 | Expiration date of the stock option. |
| October 25, 2024 | Date of the stock option exercise and sale of shares. |
| October 29, 2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.